Board Meeting24 Jul 2026, 06:00 pm
Alembic Pharma Board Meeting on Aug 4 to Approve Q1 FY27 Unaudited Results
AI Summary
Alembic Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 4, 2026. The primary agenda for this meeting is to consider and approve the company's unaudited financial results for the first quarter of the fiscal year 2027, ending June 30, 2026. Following the declaration of these results, the trading window for dealing in the company's securities will reopen 48 hours after the announcement, as per the company's code of conduct.
Key Highlights
- Board meeting scheduled for August 4, 2026.
- To consider and approve unaudited financial results.
- Financial period is for the quarter ended June 30, 2026.
- Trading window to reopen 48 hours post-results declaration.
Price Impact
More from APLLTD